WeVote

Bill

Bill

HB 107

Relating to the establishment of the sickle cell disease registry.

89th Legislature (2025) Introduced by Alma Allen and 60 co-sponsors

Texas creates statewide sickle cell disease registry to track patient data, improve research, and enhance targeted healthcare delivery for affected populations beginning September 2025.

Effective on 9/1/25
0
WeVote Research Nonpartisan
Bill Summary · HB 107

Legislative bill overview

HB 107 establishes a state sickle cell disease registry in Texas to collect and maintain data on individuals diagnosed with sickle cell disease. The registry will be administered by the Texas Department of State Health Services and aims to improve tracking, research, and health outcomes for sickle cell patients across the state.

Why is this important

Sickle cell disease disproportionately affects African American and Hispanic populations in Texas, yet comprehensive data on patient prevalence and outcomes has been fragmented across healthcare providers. A centralized registry enables public health officials to identify gaps in care, support clinical research, improve disease management programs, and allocate resources more effectively to underserved communities.

Potential points of contention

  • Data privacy concerns: Centralized patient registries raise questions about who can access sensitive health information, how it's protected, and whether individuals have adequate control over their medical data
  • Implementation costs: Establishing and maintaining a statewide registry requires sustained funding, IT infrastructure, and staffing that may strain state health agency budgets
  • Participation logistics: The registry's effectiveness depends on healthcare providers reporting cases consistently; unclear reporting requirements or lack of provider incentives could result in incomplete data

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.